Abstract
HIV-associated nephropathy (HIVAN) is a renal disease that affects HIV+ people of African ancestry with a high viral load and a genetic predisposition to develop this disease. From the clinical point of view, HIVAN is characterized by heavy proteinuria, nephrotic syndrome, and rapid progression to end-stage kidney disease (ESKD). Renal histological studies show focal segmental glomerulosclerosis (FSGS), collapsing glomerulopathy, which is less common in children, and microcystic tubular dilatation. HIVAN has a significant clinical impact in the quality of life and survival of HIV+ children. This chapter will discuss relevant issues related to the diagnosis, pathogenesis, clinical outcome, and treatment of children with HIVAN, focusing on the most relevant renal pathological, genetic, and virological factors that precipitate this renal disease. HIV-1 infection of renal epithelial cells appears to play a key role in this process, at least partially by inducing chronic renal epithelial injury, and triggering a persistent renal inflammatory and regenerative response that leads to renal enlargement and rapid progression of the renal disease. New antiretroviral therapies (ART) have been efficient in preventing and improving the outcome of children with HIVAN, and significant progress has been made in the field of renal transplantation in HIV+ people. However, physicians have had less success providing chronic ART to HIV+ children and adolescents, and HIVAN remains a problem in children of African ancestry all over the world. In addition, some antiretroviral drugs can induce renal injury per se. Overall, better prevention and treatment programs are needed to eradicate this renal disease in children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahuja TS, Abbott KC, Pack L, Kuo YF (2004) HIV-associated nephropathy and end-stage renal disease in children in the United States. Pediatr Nephrol 19(7):808–811
Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR (2005) TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J 19(12):1637–1645
Alpers CE, McClure J, Bursten SL (1992) Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2. Am J Kidney Dis 19(2):126–130
Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, Lucas GM, Nelson GW, Warner AC, Winkler CA, Kopp JB (2012) HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int 82(3):338–343
Barasch J, Qiao J, McWilliams G, Chen D, Oliver JA, Herzlinger D (1997) Ureteric bud cells secrete multiple factors, including bFGF, which rescue renal progenitors from apoptosis. Am J Phys 273(5 Pt 2):F757–F767
Barbiano di Belgiojoso G, Genderini A, Vago L, Parravicini C, Bertoli S, Landriani N (1990) Absence of HIV antigens in renal tissue from patients with HIV-associated nephropathy. Nephrol Dial Transplant 5(7):489–492
Barisoni L, Kriz W, Mundel P, D’Agati V (1999) The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10(1):51–61
Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220(4599):868–871
Beckerman P, Bi-Karchin J, Park AS, Qiu C, Dummer PD, Soomro I, Boustany-Kari CM, Pullen SS, Miner JH, Hu CA, Rohacs T, Inoue K, Ishibe S, Saleem MA, Palmer MB, Cuervo AM, Kopp JB, Susztak K (2017) Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med 23(4):429–438
Bhagani S, Sweny P, Brook G, British HIV Association (2006) Guidelines for kidney transplantation in patients with HIV disease. HIV Med 7(3):133–139
Bhimma R, Purswani MU, Kala U (2013) Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc 16:18596
Blumberg EA, Stock P, Practice ASTIDC o (2009) Solid organ transplantation in the HIV-infected patient. Am J Transplant 9(Suppl 4):S131–S135
Bobardt MD, Saphire AC, Hung HC, Yu X, Van der Schueren B, Zhang Z, David G, Gallay PA (2003) Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 18(1):27–39
Bourgoignie JJ, Pardo V (1991) The nephropathology in human immunodeficiency virus (HIV-1) infection. Kidney Int Suppl 35:S19–S23
Bowerman B, Brown PO, Bishop JM, Varmus HE (1989) A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev 3(4):469–478
Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, Van Dyke RB, Pediatric AIDS Clinical Trials Group219/219C Team (2010) Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr 53(1):86–94
Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE (1997) Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100(1):84–92
Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D’Agati VD, Winston JA, Klotman ME, Klotman PE (2000) Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11(11):2079–2087
Bruggeman LA, O’Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC (2014) Plasma apolipoprotein L1 levels do not correlate with CKD. J Am Soc Nephrol 25(3):634–644
Bruggeman LA, Wu Z, Luo L, Madhavan SM, Konieczkowski M, Drawz PE, Thomas DB, Barisoni L, Sedor JR, O’Toole JF (2016) APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease. J Am Soc Nephrol 27(12):3600–3610
Canaud G, Dejucq-Rainsford N, Avettand-Fenoel V, Viard JP, Anglicheau D, Bienaime F, Muorah M, Galmiche L, Gribouval O, Noel LH, Satie AP, Martinez F, Sberro-Soussan R, Scemla A, Gubler MC, Friedlander G, Antignac C, Timsit MO, Onetti Muda A, Terzi F, Rouzioux C, Legendre C (2014) The kidney as a reservoir for HIV-1 after renal transplantation. J Am Soc Nephrol 25(2):407–419
Chan KT, Papeta N, Martino J, Zheng Z, Frankel RZ, Klotman PE, D’Agati VD, Lifton RP, Gharavi AG (2009) Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus. Kidney Int 75(4):366–372
Chaparro AI, Mitchell CD, Abitbol CL, Wilkinson JD, Baldarrago G, Lopez E, Zilleruelo G (2008) Proteinuria in children infected with the human immunodeficiency virus. J Pediatr 152(6):844–849
Chen P, Chen BK, Mosoian A, Hays T, Ross MJ, Klotman PE, Klotman ME (2011) Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells. J Am Soc Nephrol 22(3):496–507
Chugh S, Bird R, Alexander EA (1997) Ritonavir and renal failure. N Engl J Med 336(2):138
Cohen AH, Sun NC, Shapshak P, Imagawa DT (1989) Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 2(2):125–128
Connell BJ, Lortat-Jacob H (2013) Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition. Front Immunol 4:385
Connor E, Gupta S, Joshi V, DiCarlo F, Offenberger J, Minnefor A, Uy C, Oleske J, Ende N (1988) Acquired immunodeficiency syndrome-associated renal disease in children. J Pediatr 113(1 Pt 1):39–44
Cowan MJ, Hellmann D, Chudwin D, Wara DW, Chang RS, Ammann AJ (1984) Maternal transmission of acquired immune deficiency syndrome. Pediatrics 73(3):382–386
D’Agati V, Appel GB (1997) HIV infection and the kidney. J Am Soc Nephrol 8(1):138–152
D’Agati V, Suh JI, Carbone L, Cheng JT, Appel G (1989) Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 35(6):1358–1370
Daecke J, Fackler OT, Dittmar MT, Krausslich HG (2005) Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol 79(3):1581–1594
Das JR, Gutkind JS, Ray PE (2016) Circulating fibroblast growth factor-2, HIV-Tat, and vascular endothelial cell growth factor-A in HIV-infected children with renal disease activate Rho-A and Src in cultured renal endothelial cells. PLoS One 11(4):e0153837
Daugas E, Rougier JP, Hill G (2005) HAART-related nephropathies in HIV-infected patients. Kidney Int 67(2):393–403
Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL (1991) HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185(1):109–119
Dickie P, Ramsdell F, Notkins AL, Venkatesan S (1993) Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 197(1):431–438
Dickie P, Roberts A, Uwiera R, Witmer J, Sharma K, Kopp JB (2004) Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology 322(1):69–81
Dijkman HB, Weening JJ, Smeets B, Verrijp KC, van Kuppevelt TH, Assmann KK, Steenbergen EJ, Wetzels JF (2006) Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 70(2):338–344
Dondo V, Mujuru HA, Nathoo KJ, Chirehwa M, Mufandaedza Z (2013) Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study. BMC Pediatr 13:75
Drummond IA, Mukhopadhyay D, Sukhatme VP (1998) Expression of fetal kidney growth factors in a kidney tumor line: role of FGF2 in kidney development. Exp Nephrol 6(6):522–533
Duchateau PN, Pullinger CR, Orellana RE, Kunitake ST, Naya-Vigne J, O’Connor PM, Malloy MJ, Kane JP (1997) Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem 272(41):25576–25582
Eitner F, Cui Y, Hudkins KL, Anderson DM, Schmidt A, Morton WR, Alpers CE (1998) Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int 54(6):1945–1954
Eitner F, Cui Y, Hudkins KL, Stokes MB, Segerer S, Mack M, Lewis PL, Abraham AA, Schlondorff D, Gallo G, Kimmel PL, Alpers CE (2000) Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol 11(5):856–867
Eke FU, Anochie IC, Okpere AN, Eneh AU, Ugwu RO, Ejilemele AA, Ugboma HU (2010) Microalbuminuria in children with human immunodeficiency virus (HIV) infection in Port Harcourt, Nigeria. Niger J Med 19(3):298–301
Ekulu PM, Nseka NM, Aloni MN, Gini JL, Makulo JR, Lepira FB, Sumaili EK, Mafuta EM, Nsibu CN, Shiku JD (2012) Prevalence of proteinuria and its association with HIV/AIDS in Congolese children living in Kinshasa, Democratic Republic of Congo. Nephrol Ther 8(3):163–167
Esezobor CI, Iroha E, Onifade E, Akinsulie AO, Temiye EO, Ezeaka C (2010) Prevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria. J Trop Pediatr 56(3):187–190
Evans-Gilbert T, Pierre RB, Steel-Duncan J, Palmer P, Figueroa JP, Christie CD (2008) HIV-related mortality in Jamaican children. West Indian Med J 57(3):265–268
Fackler OT, Peterlin BM (2000) Endocytic entry of HIV-1. Curr Biol 10(16):1005–1008
Fauci AS (2003) HIV and AIDS: 20 years of science. Nat Med 9(7):839–843
Freedman BI, Soucie JM, Stone SM, Pegram S (1999) Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 34(2):254–258
Fu Y, Zhu JY, Richman A, Zhang Y, Xie X, Das JR, Li J, Ray PE, Han Z (2017) APOL1-G1 in nephrocytes induces hypertrophy and accelerates cell death. J Am Soc Nephrol 28(4):1106–1116
Gafni RI, Hazra R, Reynolds JC, Maldarelli F, Tullio AN, DeCarlo E, Worrell CJ, Flaherty JF, Yale K, Kearney BP, Zeichner SL (2006) Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. Pediatrics 118(3):e711–e718
Gallo RC (2002) Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol Rev 185:236–265
Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010a) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329(5993):841–845
Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, Needham AW, Lazarus R, Pollak MR (2010b) A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 78(7):698–704
Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D’Agati VD, Klotman PE, Lifton RP (2004) Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci USA 101(8):2488–2493
Gordillo R, Kumar J, Del Rio M, Flynn JT, Woroniecki RP (2009) Outcome of dialysis in children with human immunodeficiency virus infection. Pediatr Nephrol 24(1):171–175
Gordillo R, Del Rio M, Woroniecki RP (2011) Dialysis-associated morbidity, ultrafiltration, and cardiovascular variables in children with HIV infection. Clin Nephrol 75(5):434–439
Goto T, Harada S, Yamamoto N, Nakai M (1988) Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line. Arch Virol 102(1–2):29–38
Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305(24):1425–1431
Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83(5):793–802
Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P (1998) Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95(2):163–175
Hatsukari I, Singh P, Hitosugi N, Messmer D, Valderrama E, Teichberg S, Chaung W, Gross E, Schmidtmayerova H, Singhal PC (2007) DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J Am Soc Nephrol 18(3):780–787
Hazra R, Gafni RI, Maldarelli F, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty J, Yale K, Kearney BP, Zeichner SL (2005) Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection. Pediatrics 116(6):e846–e854
He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, Iyengar R, Klotman PE (2004) Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114(5):643–651
Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, Klotman PE (2002) HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 13(7):1806–1815
Husain M, D’Agati VD, He JC, Klotman ME, Klotman PE (2005) HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 19(17):1975–1980
Iduoriyekemwen NJ, Sadoh WE, Sadoh AE (2013) Prevalence of renal disease in Nigerian children infected with the human immunodeficiency virus and on highly active anti-retroviral therapy. Saudi J Kidney Dis Transpl 24(1):172–177
Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A (1991) Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr 119(5):710–716
Judd A, Boyd KL, Stohr W, Dunn D, Butler K, Lyall H, Sharland M, Shingadia D, Riordan A, Gibb DM (2010) Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS 24(4):525–534
Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, Dickie P (2000) Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. Kidney Int 58(3):1148–1159
Kanemoto K, Usui J, Tomari S, Yokoi H, Mukoyama M, Aten J, Weening JJ, Nagata M (2003) Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab Investig 83(11):1615–1625
Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS, Family Investigation of Nephropathy and Diabetes Research Group (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40(10):1185–1192
Katz A, Bargman JM, Miller DC, Guo JW, Ghali VS, Schoeneman MJ (1992) IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy? Clin Nephrol 38(2):61–68
Khatua AK, Taylor HE, Hildreth JE, Popik W (2010) Non-productive HIV-1 infection of human glomerular and urinary podocytes. Virology 408(1):119–127
Kline ER, Sutliff RL (2008) The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med 56(5):752–769
Kopp JB, Winkler C (2003) HIV-associated nephropathy in African Americans. Kidney Int Suppl 83:S43–S49
Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE (1992) Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 89(5):1577–1581
Kopp JB, Miller KD, Mican JA, Feuerstein IM, Vaughan E, Baker C, Pannell LK, Falloon J (1997) Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 127(2):119–125
Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40(10):1175–1184
Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22(11):2129–2137
Korgaonkar SN, Feng X, Ross MD, Lu TC, D’Agati V, Iyengar R, Klotman PE, He JC (2008) HIV-1 upregulates VEGF in podocytes. J Am Soc Nephrol 19(5):877–883
Kriz W, Hahnel B, Rosener S, Elger M (1995) Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 48(5):1435–1450
Kruzel-Davila E, Shemer R, Ofir A, Bavli-Kertselli I, Darlyuk-Saadon I, Oren-Giladi P, Wasser WG, Magen D, Zaknoun E, Schuldiner M, Salzberg A, Kornitzer D, Marelja Z, Simons M, Skorecki K (2017) APOL1-mediated cell injury involves disruption of conserved trafficking processes. J Am Soc Nephrol 28(4):1117–1130
Kumar MS, Sierka DR, Damask AM, Fyfe B, McAlack RF, Heifets M, Moritz MJ, Alvarez D, Kumar A (2005) Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 67(4):1622–1629
Lam AQ, Freedman BS, Morizane R, Lerou PH, Valerius MT, Bonventre JV (2014) Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 25(6):1211–1225
Lan X, Jhaveri A, Cheng K, Wen H, Saleem MA, Mathieson PW, Mikulak J, Aviram S, Malhotra A, Skorecki K, Singhal PC (2014) APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. Am J Physiol Renal Physiol 307(3):F326–F336
Lan X, Wen H, Saleem MA, Mikulak J, Malhotra A, Skorecki K, Singhal PC (2015) Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu. Exp Mol Pathol 98(3):491–501
Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, Conte S, Genovese G, Ross MD, Friedman DJ, Gaston R, Milford E, Pollak MR, Chandraker A (2012) The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant 12(7):1924–1928
Li J, Das JR, Tang P, Han Z, Jaiswal JK, Ray PE (2017) Transmembrane TNF-alpha facilitates HIV-1 infection of podocytes cultured from children with HIV-associated nephropathy. J Am Soc Nephrol 28(3):862–875
Limou S, Dummer PD, Nelson GW, Kopp JB, Winkler CA (2015) APOL1 toxin, innate immunity, and kidney injury. Kidney Int 88(1):28–34
Lindegren ML, Steinberg S, Byers RH Jr (2000) Epidemiology of HIV/AIDS in children. Pediatr Clin N Am 47(1):1–20
Liu XH, Aigner A, Wellstein A, Ray PE (2001) Up-regulation of a fibroblast growth factor binding protein in children with renal diseases. Kidney Int 59(5):1717–1728
Locke JE, Gustafson S, Mehta S, Reed RD, Shelton B, MacLennan PA, Durand C, Snyder J, Salkowski N, Massie A, Sawinski D, Segev, DL (2016) Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg
Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC, HIV Medicine Association of the Infectious Diseases Society of America (2014) Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 59(9):e96–138
Luzuriaga K, McManus M, Mofenson L, Britto P, Graham B, Sullivan JL, Investigators P (2004) A trial of three antiretroviral regimens in HIV-1-infected children. N Engl J Med 350(24):2471–2480
Madhavan SM, O’Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR (2011) APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 22(11):2119–2128
Marechal V, Clavel F, Heard JM, Schwartz O (1998) Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol 72(3):2208–2212
Margolis D, Heredia A, Gaywee J, Oldach D, Drusano G, Redfield R (1999) Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J Acquir Immune Defic Syndr 21(5):362–370
Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D’Agati VD, Hahn BH, Klotman ME, Klotman PE (2002) Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 8(5):522–526
McCulloch MI, Ray PE (2008) Kidney disease in HIV-positive children. Semin Nephrol 28(6):585–594
Mialou V, Bertrand Y, Bouvier R, Nochy D, Fabien N, Nicoud P, Pondarre C, Meunier S, Philippe N, Cochat P (2001) Lupus nephritis in a child with AIDS. Am J Kidney Dis 37(4):E27
Mikulak J, Teichberg S, Arora S, Kumar D, Yadav A, Salhan D, Pullagura S, Mathieson PW, Saleem MA, Singhal PC (2010) DC-specific ICAM-3-grabbing nonintegrin mediates internalization of HIV-1 into human podocytes. Am J Physiol Renal Physiol 299(3):F664–F673
Mikulak J, Oriolo F, Portale F, Tentorio P, Lan X, Saleem MA, Skorecki K, Singhal PC, Mavilio D (2016) Impact of APOL1 polymorphism and IL-1beta priming in the entry and persistence of HIV-1 in human podocytes. Retrovirology 13(1):63
Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137(3):433–444
Monajemi H, Fontijn RD, Pannekoek H, Horrevoets AJ (2002) The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79(4):539–546
Muller E, Kahn D, Mendelson M (2010) Renal transplantation between HIV-positive donors and recipients. N Engl J Med 362(24):2336–2337
Nichols B, Jog P, Lee JH, Blackler D, Wilmot M, D’Agati V, Markowitz G, Kopp JB, Alper SL, Pollak MR, Friedman DJ (2015) Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int 87(2):332–342
Nourse PJ, Cotton MF, Bates WD (2010) Renal manifestations in children co-infected with HIV and disseminated tuberculosis. Pediatr Nephrol 25(9):1759–1763
Ohse T, Pippin JW, Chang AM, Krofft RD, Miner JH, Vaughan MR, Shankland SJ (2009) The enigmatic parietal epithelial cell is finally getting noticed: a review. Kidney Int 76(12):1225–1238
Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S 3rd, Heneghan JF, Schlondorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR (2016a) APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc Natl Acad Sci USA 113(4):830–837
Olabisi O, Al-Romaih K, Henderson J, Tomar R, Drummond I, MacRae C, Pollak M (2017b) From man to fish: what can Zebrafish tell us about ApoL1 nephropathy? Clin Nephrol Supplement 1: 86(13):114–118
Oleske J, Minnefor A, Cooper R Jr, Thomas K, dela Cruz A, Ahdieh H, Guerrero I, Joshi VV, Desposito F (1983) Immune deficiency syndrome in children. JAMA 249(17):2345–2349
Papaleo A, Warszawski J, Salomon R, Jullien V, Veber F, Dechaux M, Blanche S (2007) Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir. Pediatr Infect Dis J 26(10):949–951
Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ (1984) Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101(4):429–434
Pardo V, Meneses R, Ossa L, Jaffe DJ, Strauss J, Roth D, Bourgoignie JJ (1987) AIDS-related glomerulopathy: occurrence in specific risk groups. Kidney Int 31(5):1167–1173
Patzer L (2008) Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 23(12):2159–2173
Perazzo S, Soler-Garcia AA, Hathout Y, Das JR, Ray PE (2015) Urinary biomarkers of kidney diseases in HIV-infected children. Proteomics Clin Appl 9(5–6):490–500
Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, Homble F, Vanhamme L, Tebabi P, Pays A, Poelvoorde P, Jacquet A, Brasseur R, Pays E (2005) Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309(5733):469–472
Purswani MU, Chernoff MC, Mitchell CD, Seage GR 3rd, Zilleruelo G, Abitbol C, Andiman WA, Kaiser KA, Spiegel H, Oleske JM, IMPAACT 219/219C Study Team (2012) Chronic kidney disease associated with perinatal HIV infection in children and adolescents. Pediatr Nephrol 27(6):981–989
Rajpoot D, Kaupke CJ, Vaziri ND, Rao TK, Pomrantz A, Fikrig S (1996) Childhood AIDS nephropathy: a 10-year experience. J Natl Med Assoc 88(8):493–498
Ramsuran D, Bhimma R, Ramdial PK, Naicker E, Adhikari M, Deonarain J, Sing Y, Naicker T (2012) The spectrum of HIV-related nephropathy in children. Pediatr Nephrol 27(5):821–827
Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA (1984) Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310(11):669–673
Ratnam KK, He CJ, Klotman P (2008) Nef as a proliferative factor for kidney epithelial cells in HIV-associated nephropathy. Clin Med Oncol 2:539–545
Ray PE, Hu CA (2011) Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children. Future Virol 6(7):883–894
Ray PE, Bruggeman LA, Weeks BS, Kopp JB, Bryant JL, Owens JW, Notkins AL, Klotman PE (1994) bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney Int 46(3):759–772
Ray PE, Liu XH, Henry D, Dye L 3rd, Xu L, Orenstein JM, Schuztbank TE (1998a) Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 53(5):1217–1229
Ray PE, Rakusan T, Loechelt BJ, Selby DM, Liu XH, Chandra RS (1998b) Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years’ experience. Semin Nephrol 18(4):396–405
Ray PE, Liu XH, Xu L, Rakusan T (1999) Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome. Pediatr Nephrol 13(7):586–593
Ray PE, Liu XH, Robinson LR, Reid W, Xu L, Owens JW, Jones OD, Denaro F, Davis HG, Bryant JL (2003) A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney Int 63(6):2242–2253
Ray PE, Tassi E, Liu XH, Wellstein A (2006) Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome. Am J Physiol Regul Integr Comp Physiol 290(1):R105–R113
Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, Gautreaux MD, Divers J, Freedman BI (2011) The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11(5):1025–1030
Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O’Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 98(16):9271–9276
Riordan A, Judd A, Boyd K, Cliff D, Doerholt K, Lyall H, Menson E, Butler K, Gibb D, Collaborative HIV Paediatric Study (2009) Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland. Pediatr Infect Dis J 28(3):204–209
Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG (2008) HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 8(2):355–365
Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD (2006) HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 42(10):1488–1495
Ronconi E, Sagrinati C, Angelotti ML, Lazzeri E, Mazzinghi B, Ballerini L, Parente E, Becherucci F, Gacci M, Carini M, Maggi E, Serio M, Vannelli GB, Lasagni L, Romagnani S, Romagnani P (2009) Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20(2):322–332
Rubinstein A, Sicklick M, Gupta A, Bernstein L, Klein N, Rubinstein E, Spigland I, Fruchter L, Litman N, Lee H, Hollander M (1983) Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA 249(17):2350–2356
Sasaki T, Hatta H, Osawa G (1999) Cytokines and podocyte injury: the mechanism of fibroblast growth factor 2-induced podocyte injury. Nephrol Dial Transplant 14(Suppl 1):33–34
Sawinski D (2017) Kidney transplantation for HIV-positive patients. Transplant Rev 3:42–46
Schwarz A, Offermann G, Keller F, Bennhold I, L’Age-Stehr J, Krause PH, Mihatsch MJ (1993) The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature. Transplantation 55(1):95–103
Shah I, Gupta S, Shah DM, Dhabe H, Lala M (2012) Renal manifestations of HIV infected highly active antiretroviral therapy naive children in India. World J Pediatr 8(3):252–255
Shirai A, Klinman DM (1993) Immunization with recombinant gp160 prolongs the survival of HIV-1 transgenic mice. AIDS Res Hum Retrovir 9(10):979–983
Singhal PC, Sagar S, Chandra D, Garg P (1995) Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity. Am J Pathol 147(1):25–32
Smith EE, Malik HS (2009) The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res 19(5):850–858
Soler-Garcia AA, Johnson D, Hathout Y, Ray PE (2009a) Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases. Clin J Am Soc Nephrol 4(4):763–771
Soler-Garcia AA, Rakhmanina NY, Mattison PC, Ray PE (2009b) A urinary biomarker profile for children with HIV-associated renal diseases. Kidney Int 76(2):207–214
Steel-Duncan J, Miller M, Pierre RB, Dunkley-Thompson J, Palmer P, Evans-Gilbert T, Rodriquez B, Christie CD, Kingston Paediatric and Perinatal HIV/AIDS Study Group (2008) Renal manifestations in HIV-infected Jamaican children. West Indian Med J 57(3):246–252
Stevenson M (2003) HIV-1 pathogenesis. Nat Med 9(7):853–860
Stock PG, Roland ME (2007) Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation 84(5):563–571
Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL (2003) Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 76(2):370–375
Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME (2010) Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 363(21):2004–2014
Strauss J, Abitbol C, Zilleruelo G, Scott G, Paredes A, Malaga S, Montane B, Mitchell C, Parks W, Pardo V (1989a) Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 321(10):625–630
Strauss J, Abitbol C, Zilleruelo G, Scott G, Paredes A, Mitchell C, Parks W, Pardo V (1989b) HIV-associated nephropathy. J Pediatr 114(2):336
Streblow DN, Kitabwalla M, Malkovsky M, Pauza CD (1998) Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. Virology 245(2):197–202
Szczech LA, Menezes P, Byrd Quinlivan E, van der Horst C, Bartlett JA, Svetkey LP (2010) Microalbuminuria predicts overt proteinuria among patients with HIV infection. HIV Med 11(7):419–426
Tang P, Jerebtsova M, Przygodzki R, Ray PE (2005) Fibroblast growth factor-2 increases the renal recruitment and attachment of HIV-infected mononuclear cells to renal tubular epithelial cells. Pediatr Nephrol 20(12):1708–1716
Taylor HE, Khatua AK, Popik W (2014) The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol 88(1):592–603
Tourret J, Tostivint I, du Montcel ST, Bragg-Gresham J, Karie S, Vigneau C, Guiard-Schmid JB, Deray G, Bagnis CI (2006) Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin J Am Soc Nephrol 1(6):1241–1247
Touzot M, Pillebout E, Matignon M, Tricot L, Viard JP, Rondeau E, Legendre C, Glotz D, Delahousse M, Lang P, Peraldi MN (2010) Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant 10(10):2263–2269
Trachtman H, Gauthier B, Vinograd A, Valderrama E (1991) IgA nephropathy in a child with human immunodeficiency virus type 1 infection. Pediatr Nephrol 5(6):724–726
Turner ME, Kher K, Rakusan T, D'Angelo L, Kapur S, Selby D, Ray PE (1997) A typical hemolytic uremic syndrome in human immunodeficiency virus-1-infected children. Pediatr Nephrol 11(2):161–163
Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE (1990) Transplantation in HIV+ patients. Transplantation 49(2):354–358
Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K (2010) Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128(3):345–350
Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong H, Jacquet A, Moguilevsky N, Dieu M, Kane JP, De Baetselier P, Brasseur R, Pays E (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422(6927):83–87
Vermund SH, Blevins M, Moon TD, Jose E, Moiane L, Tique JA, Sidat M, Ciampa PJ, Shepherd BE, Vaz LM (2014) Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS One 9(10):e110116
Vigano A, Zuccotti GV, Puzzovio M, Pivetti V, Zamproni I, Cerini C, Fabiano V, Giacomet V, Mora S (2010) Tenofovir disoproxil fumarate and bone mineral density: a 60-month longitudinal study in a cohort of HIV-infected youths. Antivir Ther 15(7):1053–1058
Waheed S, Sakr A, Chheda ND, Lucas GM, Estrella M, Fine DM, Atta MG (2015) Outcomes of renal transplantation in HIV-1 associated nephropathy. PLoS One 10(6):e0129702
Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA (2008) Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem 283(31):21540–21549
Wearne N, Swanepoel CR, Boulle A, Duffield MS, Rayner BL (2012) The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol Dial Transplant 27(11):4109–4118
Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL (2003) Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 64(4):1462–1471
Weiss MA, Daquioag E, Margolin EG, Pollak VE (1986) Nephrotic syndrome, progressive irreversible renal failure, and glomerular “collapse”: a new clinicopathologic entity? Am J Kidney Dis 7(1):20–28
Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D’Agati VD, Klotman PE, Klotman ME (2001) Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344(26):1979–1984
Xie X, Colberg-Poley AM, Das JR, Li J, Zhang A, Tang P, Jerebtsova M, Gutkind JS, Ray PE (2014) The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy. J Am Soc Nephrol 25(8):1800–1813
Zhang YJ, Hatziioannou T, Zang T, Braaten D, Luban J, Goff SP, Bieniasz PD (2002) Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection. J Virol 76(12):6332–6343
Zhaorigetu S, Wan G, Kaini R, Jiang Z, Hu CA (2008) ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death. Autophagy 4(8):1079–1082
Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T (2005) Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68(3):1048–1060
Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G (2006) Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis 42(2):283–290
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Ray, P.E. (2019). HIVAN, Pediatric. In: Trachtman, H., Herlitz, L., Lerma, E., Hogan, J. (eds) Glomerulonephritis. Springer, Cham. https://doi.org/10.1007/978-3-319-49379-4_32
Download citation
DOI: https://doi.org/10.1007/978-3-319-49379-4_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49378-7
Online ISBN: 978-3-319-49379-4
eBook Packages: MedicineReference Module Medicine